MicroOptx
Maple Grove
About MicroOptx
MicroOptx is an early-stage medical device company that leverages academic bioengineering, surgical expertise, microengineering manufacturing, and nanotechnology to provide the modern solution for the vexing problem of Glaucoma. It develops a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye. The company is driven by a mission is to change the way the world treats glaucoma: and to halt the devastating effects of this progressive disease. MicroOptx is led by recognized medical, industry and financial veterans who are dedicated to preventing blindness.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.2M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2019)
- Website: microoptx.com
- Phone: (763) 670-5600
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/microoptx-122344 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.